12 Nov 2008 17:04
RNS Number : 0504I
e-Therapeutics plc
12 November 2008
e-Therapeutics plc
("e-Therapeutics" or "the Company")
Share Option Award
e-Therapeutics (AIM: ETX), the drug discovery and development company, announces that on 12 November, 2008 Brad Hoy was awarded options to subscribe for 80,000 new ordinary shares of 0.1p each in the Company ("Ordinary Shares) at an exercise price of 37.5p per share. The options are valid for immediate exercise and expire on 30 November 2012.
Following this award, Brad Hoy has options to acquire 80,000 Ordinary Shares and holds no other options or Ordinary Shares.
|
For further information: |
e-Therapeutics plc | www.etherapeutics.co.uk | Malcolm Young malcolm@etherapeutics.co.uk | +44 (0) 191 233 1317 | | | Nominated Adviser: WH Ireland | | Katy Mitchell katy.mitchell@wh-ireland.co.uk | +44 (0)113 394 6628 | |
Broker: Cornhill Asset Management | | Tom Whitehead tomw@cornhillassetmanagement.com | +44 (0) 20 7645 8327 | Andrew Houchin andrewh@cornhillassetmanagement.com | +44 (0) 20 7743 6468 | |
|
Media enquiries: |
|
Abchurch | www.abchurch-group.com | Heather Salmond heather.salmond@abchurch-group.com | Tel: +44 (0) 20 7398 7704 | Stephanie Cuthbert stephanie.cuthbert@abchurch-group.com | Tel: +44 (0) 20 7398 7718 | Simone Alves simone.alves@abchurch-group.com | Tel: +44 (0) 20 7398 7728 | |
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCBRBDBXGBGGID